2m 2m 2m 2m 2m 2m 2m
Thermo Fisher Sc (TMO)
NYSE
$467.83+$3.82 (+0.82%)
Price as of Jun 23, 2026 6:44 PM EDT- $172.4BMarket Cap
- 16.36%1-Year Change
- Diagnostics & ResearchIndustry
Thermo Fisher Sc (TMO)
$467.83+$3.82 (+0.82%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 26.0B -39.45% | 42.9B +0.05% | 42.9B -4.58% | 44.9B +14.55% | |
Cost of Revenue | 13.4B -46.76% | 25.2B -2.25% | 25.8B -0.72% | 25.9B +32.55% | |
Gross Profit | 12.6B -29.05% | 17.7B +3.52% | 17.1B -9.86% | 19.0B -3.40% | |
Sales and Marketing Expense | 8.7B +1.59% | 8.6B +1.78% | 8.4B -6.09% | 9.0B +12.31% | |
Research and Development Expense | -1.4B +0.50% | -1.4B +3.96% | -1.3B -9.11% | -1.5B +4.62% | |
Depreciation and Amortization Expense | 1.7B -11.37% | 2.0B -16.51% | 2.3B -2.38% | 2.4B +36.00% | |
Total Operating Expenses | 36.8B +3.57% | 35.5B -1.27% | 36.0B -1.43% | 36.5B +25.15% | |
Operating Profit | 7.7B +5.57% | 7.3B +6.97% | 6.9B -18.28% | 8.4B -16.30% | |
Interest Income | 993.0M -7.88% | 1.1B +22.64% | 879.0M +223.16% | 272.0M +532.56% | |
Interest Expense | N/A N/A | N/A N/A | -1.4B +89.39% | -726.0M +35.45% | |
Interest Income and Expense and Net | 993.0M -7.88% | 1.1B +317.34% | -496.0M +9.25% | -454.0M -7.91% | |
Total Nonoperating Income and Expense | -12.0M -200.00% | 12.0M +118.46% | -65.0M -37.50% | -104.0M -85.01% | |
Income before Taxes | 7.3B +3.85% | 7.0B +11.73% | 6.3B -19.62% | 7.8B -11.38% | |
Income Taxes | 547.0M -16.74% | 657.0M +131.34% | 284.0M -59.60% | 703.0M -36.61% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 6.7B +5.77% | 6.3B +6.43% | 6.0B -14.44% | 7.0B -9.94% | |
Net Income from Continuing Operations Applicable to Common | 6.7B +5.82% | 6.3B +5.67% | 6.0B -13.74% | 7.0B -10.03% | |
Basic EPS and Net Income | 17.77 +7.18% | 16.58 +6.83% | 15.52 -12.56% | 17.75 -9.53% | |
Diluted EPS and Net Income | 17.74 +7.32% | 16.53 +6.99% | 15.45 -12.37% | 17.63 -9.40% | |
Basic Weighted Average Shares | 377.0M -1.31% | 382.0M -1.04% | 386.0M -1.53% | 392.0M -0.51% | |
Diluted Weighted Average Shares | 378.0M -1.31% | 383.0M -1.29% | 388.0M -1.52% | 394.0M -0.76% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.9B +145.75% | 4.0B -50.37% | 8.1B -5.24% | 8.5B +90.40% | |
Short-Term Investments | 253.0M -83.79% | 1.6B N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 10.1B +81.42% | 5.6B -31.04% | 8.1B -5.24% | 8.5B +90.40% | |
Total Current Assets | 28.7B +29.68% | 22.1B -9.97% | 24.6B -2.54% | 25.2B +25.44% | |
Accumulated Depreciation | 7.8B +15.73% | 6.8B +11.14% | 6.1B +21.79% | 5.0B +17.11% | |
Property and Plant and Equipment and Net | 10.6B +13.53% | 9.3B -1.50% | 9.4B +1.81% | 9.3B +11.36% | |
Total Long-Term Assets | 5.9B +30.70% | 4.5B +12.33% | 4.0B -0.20% | 4.0B -13.64% | |
Total Assets | 110.3B +13.38% | 97.3B -1.42% | 98.7B +1.62% | 97.2B +2.14% | |
Income Taxes Payable | 1.5B +17.74% | 1.3B -34.03% | 1.9B -32.54% | 2.8B -25.75% | |
Total Short-Term Debt | 3.5B +59.58% | 2.2B -38.65% | 3.6B -35.31% | 5.6B +119.91% | |
Total Current Liabilities | 15.2B +13.93% | 13.3B -4.85% | 14.0B -17.62% | 17.0B +26.60% | |
Total Long-Term Debt | 35.9B +23.37% | 29.1B -7.18% | 31.3B +8.30% | 28.9B -10.59% | |
Total Long-Term Liabilities | 4.3B +7.12% | 4.0B -14.07% | 4.6B +9.53% | 4.2B -6.65% | |
Total Liabilities | 15.2B +13.93% | 13.3B -4.85% | 14.0B -17.62% | 17.0B +26.60% | |
Retained Earnings | 59.2B +11.40% | 53.1B +12.11% | 47.4B +13.01% | 41.9B +18.29% | |
Total Stockholders Equity | 53.4B +7.71% | 49.6B +6.10% | 46.7B +6.27% | 44.0B +7.81% | |
Total Shares Outstanding | 445.2M +0.30% | 443.8M +0.37% | 442.2M +0.35% | 440.7M +0.34% | |
Cash Flow | |||||
Cash from Operating Activities | 7.8B -9.80% | 8.7B +3.10% | 8.4B -8.17% | 9.2B -1.70% | |
Capital Expenditures | 1.5B +8.93% | 1.4B -5.34% | 1.5B -34.06% | 2.2B -11.10% | |
Cash from Investing Activities | -4.0B -30.71% | -5.8B +13.59% | -5.1B +138.17% | -2.2B -90.16% | |
Dividends Paid | 636.0M +9.09% | 583.0M +11.47% | 523.0M +14.95% | 455.0M +15.19% | |
Cash from Financing Activities | 1.8B +126.52% | -6.8B +87.52% | -3.6B +28.90% | -2.8B -142.70% | |
Financials Ratio | |||||
Gross Margin | 48.37% +17.17% | 41.28% +3.47% | 39.90% -5.53% | 42.24% -15.66% | |
Operating Margin | 29.83% +74.35% | 17.11% +6.91% | 16.00% -14.35% | 18.69% -26.93% | |
Return on Assets | 6.46% -0.14% | 6.47% +6.34% | 6.08% -16.01% | 7.24% -23.10% | |
Return on Equity | 13.02% -1.08% | 13.16% +0.24% | 13.13% -20.04% | 16.42% -20.00% | |
Revenue Growth | -39.45% -76,992.59% | 0.05% +101.12% | -4.58% -131.50% | 14.55% -32.98% | |
Current Ratio | 1.89 +13.83% | 1.66 -5.38% | 1.75 +18.32% | 1.48 -0.92% | |
Cash Ratio | 0.65 +115.70% | 0.30 -47.83% | 0.58 +15.03% | 0.50 +50.39% | |
Debt-to-Equity Ratio | 0.74 +16.93% | 0.63 -15.58% | 0.75 -4.73% | 0.78 -8.26% | |
Debt-to-Assets Ratio | 0.36 +11.05% | 0.32 -9.13% | 0.35 -0.37% | 0.36 -3.16% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow